Henry D, Brent P, Whyte I, Mihaly G, Devenish-Meares S
Discipline of Clinical Pharmacology, Faculty of Medicine, Royal Newcastle Hospital, Australia.
Eur J Clin Pharmacol. 1987;33(4):369-73. doi: 10.1007/BF00637632.
In a randomised double-blind cross-over study, 8 normal subjects received propranolol 80 mg twice daily with omeprazole 20 mg or identical placebo each morning. Propranolol kinetics were measured on day 8 of both treatment periods. Areas under the propranolol concentration/time curves were not significantly increased by omeprazole treatment: off treatment mean 787.6, on treatment 802.5 ng-1.ml.h. Maximum and minimum steady-state propranolol concentrations were similarily unaffected. Omeprazole also failed to increase the clinical effect of propranolol, as assessed by exercise tests on Day 8 of treatment. We conclude that omeprazole in the dose likely to be used for peptic ulcer has no significant effect on the kinetics or action of propranolol.
在一项随机双盲交叉研究中,8名正常受试者每日两次服用80毫克普萘洛尔,并在每天早晨同时服用20毫克奥美拉唑或相同的安慰剂。在两个治疗期的第8天测量普萘洛尔的动力学。奥美拉唑治疗并未使普萘洛尔浓度/时间曲线下面积显著增加:未治疗时平均为787.6,治疗时为802.5纳克⁻¹·毫升·小时。普萘洛尔的最大和最小稳态浓度同样未受影响。通过治疗第8天的运动试验评估,奥美拉唑也未能增强普萘洛尔的临床效果。我们得出结论,可能用于治疗消化性溃疡的剂量的奥美拉唑对普萘洛尔的动力学或作用无显著影响。